[HTML][HTML] Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - frontiersin.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies.

M Biswas, N Sawajan, T Rungrotmongkol, K Sanachai… - 2022 - cabidigitallibrary.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - europepmc.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

M Biswas, N Sawajan… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

M Biswas, N Sawajan… - Frontiers in …, 2022 - mahidol.elsevierpure.com
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

[HTML][HTML] Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - frontiersin.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

[PDF][PDF] Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Front. Pharmacol. 13: 835136. doi: 10.3389/fphar …

M Biswas, N Sawajan, T Rungrotmongkol… - … www. frontiersin. org, 2022 - scienceopen.com
ABCB1, SLCO1B1, APOA5; efavirenz–CYP2B6; nevirapine–HLA, CYP2B6, ABCB1;
lopinavir–SLCO1B3, ABCC2; ribavirin–SLC28A2; tocilizumab–FCGR3A; ivermectin …

[HTML][HTML] Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

[引用][C] Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - jglobal.jst.go.jp
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19
Therapies | Article Information | J-GLOBAL Art J-GLOBAL ID:202202241867305905 …

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - europepmc.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …